1.Development of a computerized automatic identification system for use in cephalometry.
Shipei LI ; Qiuliang WU ; Hengyi ZHANG
Chinese Journal of Stomatology 2002;37(6):466-468
OBJECTIVETo establish the automatic X-ray cephalometric analysis system to simplify cephalometric steps and to provide a convenient and reliable method for cephalometric analysis.
METHODSThe system which was programmed by visual-c language, and graphics and image processing techniques and artificial intelligence were used. The techniques related to computer digital image processing and pattern recognition such as Median filtering, Histogram equalization, Laplacian and Canny edge detection were introduced. It could automatically outline the contour lines of the hard and soft tissues by establishing the templates of the variable anatomical structures.
RESULTSThe following functions were established: (1) automatically outlining the contour lines of the soft tissues. (2) automatically recognizing, measuring and analysing the landmarks of soft tissues. (3) automatically recognizing porion, sella and the landmarks of the mandible. (4) automatically building the contour lines of the hard tissues. In brief, the system used the more advanced methods, calculated more precisely and saved more time and energy than other systems.
CONCLUSIONThe system is a more convenient and precise tool in cephalometry.
Cephalometry ; methods ; Humans ; Image Processing, Computer-Assisted ; Jaw ; anatomy & histology ; diagnostic imaging ; Orthodontics ; methods ; Radiography ; Sensitivity and Specificity
2.Correlation between serum human epididymis protein 4 levels and proteinuria in type 2 diabetes patients
Chunyan BO ; Shipei ZHANG ; Jinshen CHU ; Guohui XUE ; Fang WAN ; Junda CAO ; Keqi CHEN ; Jing CHEN ; Xiaofeng LIU ; Xueli CHEN
China Modern Doctor 2024;62(33):1-5
Objective To investigate the correlation of human epididymis protein 4(HE4)with proteinuria in patients with type 2 diabetes mellitus(T2DM).Methods A total of 147 T2DM patients from January 2020 to July 2023 in Jiujiang NO.l People's Hospital were enrolled in observation group.According to the severity of proteinuria,observation group was divided into three groups:Normal albuminuria group(101 cases),microalbuminuria group(25 cases),and massive albuminuria group(21 cases).50 healthy examinees with gender and age matching during the same period were selected as control group.HE4 levels and clinical indicators in each group were compared and analyzed.Correlation between HE4 and proteinuria was analyzed by using univariate and multivariate linear regression.Results The correlation network diagram reveals that HE4 functions was a pivotal node linking serum albumin,urinary microalbumin,urinary microalbumin-to-creatinine ratio(UACR),and renal function biomarkers.Compared to control group,HE4 levels significantly elevated in observation group(P<0.01).Both univariate and multivariate linear regression analysis demonstrate a positive correlation between HE4 and UACR.Logistic regression analysis shew that after adjusting for confounding factors including age,gender,estimated glomerular filtration rate(eGFR),albumin(ALB),blood urea nitrogen(BUN),serum creatinine(SCr),uric acid(UA),lactate dehydrogenase(LDH)etc.elevated HE4 levels was a risk factor for proteinuria(OR=1.110,95%CI:1.005-1.226).Conclusion Elevated HE4 levels in patients with T2DM is positivly correlated with UACR.Increase its level increases the risk of proteinuria in T2DM patients.
3.The Main Mechanisms of Mesenchymal Stem Cell-Based Treatments against COVID-19
Jinling LI ; Shipei HE ; Hang YANG ; Lizeai ZHANG ; Jie XIAO ; Chaoyi LIANG ; Sijia LIU
Tissue Engineering and Regenerative Medicine 2024;21(4):545-556
BACKGROUND:
Coronavirus disease 2019 (COVID-19) has a clinical manifestation of hypoxic respiratory failure and acute respiratory distress syndrome. However, COVID-19 still lacks of effective clinical treatments so far. As a promising potential treatment against COVID-19, stem cell therapy raised recently and had attracted much attention. Here we review the mechanisms of mesenchymal stem cell-based treatments against COVID-19, and provide potential cues for the effective control of COVID-19 in the future.
METHODS:
Literature is obtained from databases PubMed and Web of Science. Key words were chosen for COVID- 19, acute respiratory syndrome coronavirus 2, mesenchymal stem cells, stem cell therapy, and therapeutic mechanism. Then we summarize and critically analyze the relevant articles retrieved.
RESULTS:
Mesenchymal stem cell therapy is a potential effective treatment against COVID-19. Its therapeutic efficacy is mainly reflected in reducing severe pulmonary inflammation, reducing lung injury, improving pulmonary function, protecting and repairing lung tissue of the patients. Possible therapeutic mechanisms might include immunoregulation, antiinflammatory effect, tissue regeneration, anti-apoptosis effect, antiviral, and antibacterial effect, MSC - EVs, and so on.
CONCLUSION
Mesenchymal stem cells can effectively treat COVID-19 through immunoregulation, anti-inflammatory, tissue regeneration, anti-apoptosis, anti-virus and antibacterial, MSC - EVs, and other ways. Systematically elucidating the mechanisms of mesenchymal stem cell-based treatments for COVID-19 will provide novel insights into the follow-up research and development of new therapeutic strategies in next step.
4.Effect analysis of endolymphatic sac surgery on Meniere’s disease based on propensity score matching
Yu SI ; Shipei ZHUO ; Yan HUANG ; Wuhui HE ; Jingman DENG ; Jintao LOU ; Zhigang ZHANG
Chinese Journal of Clinical Medicine 2025;32(2):165-170
Objective To analyse the clinical efficiency of endolymphatic sac surgery (ESS) in the management of Meniere’s disease (MD). Methods A retrospective analysis was conducted on 274 patients with MD who were hospitalized for treatment in Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University from January 2009 to August 2023. All patients received lifestyle management and drug treatment such as diuretics. For those whose conditions were not well controlled 3 to 6 months after the initial treatment, intratympanic glucocorticoid (ITG) or ESS treatment was carried out. Six months after the treatment, the classes of vertigo relief and hearing changes in the patients were evaluated. After adjusting the confounding factors through propensity score matching (PSM), the impact of ESS on the prognosis of MD patients was evaluated. Results Among 274 patients, 194 and 80 patients underwent ITG and ESS, respectively. Eighty patients were enrolled into each group after PSM. Before and after PSM, the rate of patients reaching vertigo relief class A in ESS group was higher than that in the ITG group (P=0.004); there was no significant difference in hearing preservation between the two groups. Kaplan-Meier curve analysis showed that vertigo relief in the ESS group was better than that in the ITG group (P=0.029); there was no statistically significant difference in hearing preservation between the two groups. Conclusion When the initial treatment for patients with MD is ineffective, choosing ESS is more beneficial than ITG for controlling vertigo.